← Back to Clinical Trials
Recruiting NCT06769672

NCT06769672 Dual-task Training Combined With tDCS on Cognitive-motor Performance and Brain Activity in Stroke Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06769672
Status Recruiting
Phase —
Sponsor The Hong Kong Polytechnic University
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 72 participants
Start Date 2025-01-01
Primary Completion 2027-04-30

Eligibility & Interventions

Sex All sexes
Min Age 50 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
active tDCS with dual-task trainingsham tDCS with dual-task training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 72 participants in total. It began in 2025-01-01 with a primary completion date of 2027-04-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to evaluate the effects of tDCS combined with cognitive-motor training on dual-task interference during walking and foot pedaling, alongside corresponding alterations in brain activity assessed via fNIRS. Additionally, an fMRI component was conducted as a nested sub-study for deep mechanistic exploration.

Eligibility Criteria

Inclusion Criteria: * a diagnosis of stroke, stroke onset of more than 6 months, * aged 50 or more, * capable of following verbal and visual instructions, * having a Montreal Cognitive Assessment score ≥ 22, * able to walk for 10 meters with/without a mobility aid, * community-dwelling, unilateral stroke Exclusion Criteria: * neurological disorders, gait-precluding pain or comorbidity, * receiving any formal rehabilitation training, * contraindications to exercise (e.g., unstable angina), * contraindications to fNIRS, MRI, and tDCS (e.g., brain skin injury, pacemaker, metal implants in the brain), * history of seizure or epilepsy, * color blindness. * unable to walk with/without a mobility aid while responsing stimulus by the remote control

Contact & Investigator

Central Contact

Prof. Marco PANG

✉ Marco.Pang@polyu.edu.hk

📞 +852 2766 7156

Frequently Asked Questions

Who can join the NCT06769672 clinical trial?

This trial is open to participants of all sexes, aged 50 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06769672 currently recruiting?

Yes, NCT06769672 is actively recruiting participants. Contact the research team at Marco.Pang@polyu.edu.hk for enrollment information.

Where is the NCT06769672 trial being conducted?

This trial is being conducted at Hong Kong, Hong Kong.

Who is sponsoring the NCT06769672 clinical trial?

NCT06769672 is sponsored by The Hong Kong Polytechnic University. The trial plans to enroll 72 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology